Laure Gibault Selected Research

Adenocarcinoma

1/2017

Composite biomarkers defined by multiparametric immunofluorescence analysis identify ALK-positive adenocarcinoma as a potential target for immunotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laure Gibault Research Topics

Disease

15	Neoplasms (Cancer) 11/2023 - 03/2011
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 07/2012
7	Lung Neoplasms (Lung Cancer) 07/2023 - 07/2014
2	Pneumonia (Pneumonitis) 05/2023 - 01/2023
2	Leiomyosarcoma 02/2012 - 03/2009
1	Aortic Aneurysm (Aneurysm, Aortic) 03/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Disease Progression 01/2023
1	Adenocarcinoma of Lung 01/2023
1	Amyloid Plaque 01/2023
1	Infections 01/2023
1	Amyloidosis 01/2023
1	Hemorrhage 08/2021
1	Rupture 08/2021
1	Emphysema 08/2021
1	Cardiomyopathies (Cardiomyopathy) 02/2021
1	Malignant Mesothelioma 01/2020
1	HIV Infections (HIV Infection) 01/2020
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020
1	Anus Neoplasms (Anal Cancer) 01/2019
1	Adenocarcinoma 01/2017
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017
1	Primary Myelofibrosis (Myelosclerosis) 08/2012
1	Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary) 08/2012
1	Sarcoma (Soft Tissue Sarcoma) 02/2012
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2012
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2012
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2010

Drug/Important Bio-Agent (IBA)

2	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2012
2	MicroRNAs (MicroRNA)IBA 01/2020 - 08/2017
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 08/2017
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 12/2016
2	Circulating Tumor DNAIBA 12/2016 - 11/2016
1	RNA (Ribonucleic Acid)IBA 07/2023
1	TOR Serine-Threonine KinasesIBA 05/2023
1	MTOR InhibitorsIBA 05/2023
1	AntigensIBA 03/2023
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2023
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2023
1	Meropenem (Merrem)FDA LinkGeneric 01/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2023
1	Prealbumin (Transthyretin)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	HemosiderinIBA 08/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 02/2021
1	Cancer VaccinesIBA 01/2021
1	carboxyl radical (COO-)IBA 01/2020
1	X-Box Binding Protein 1IBA 01/2020
1	EndoribonucleasesIBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2020
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2019
1	Chromogranin AIBA 01/2019
1	Glucagon (Glukagon)FDA Link 01/2019
1	GhrelinIBA 01/2019
1	Calbindin 2IBA 01/2019
1	Amylases FDA Link 01/2019
1	Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Epithelial Cell Adhesion MoleculeIBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	Estrogen ReceptorsIBA 01/2019
1	pembrolizumabIBA 04/2018
1	Shiga Toxin (Shigella Toxin)IBA 01/2017
1	Anaplastic Lymphoma KinaseIBA 01/2017
1	Cell-Free Nucleic AcidsIBA 11/2016
1	ProstaglandinsIBA 08/2012
1	Bevacizumab (Avastin)FDA Link 07/2012
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2012
1	Pemetrexed (MTA)FDA Link 07/2012
1	romiplostim FDA Link 01/2012
1	Thrombopoietin ReceptorsIBA 01/2012
1	LigandsIBA 03/2011
1	Erythropoietin FDA Link 11/2010
1	HematinicsIBA 11/2010
1	myocardinIBA 03/2009

Therapy/Procedure

5	Immunotherapy 11/2023 - 03/2011
5	Therapeutics 01/2023 - 02/2012
1	Precision Medicine 01/2020
1	Drug Therapy (Chemotherapy) 04/2018
1	Induction Chemotherapy 11/2015
1	Lymph Node Excision (Lymph Node Dissection) 07/2014
1	Salvage Therapy 01/2012